We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AWKNF Awakn Life Sciences Corporation (QB)

-0.01 (-6.67%)
May 21 2024 - Closed
Delayed by 15 minutes

Awakn Life Sciences (QB) Financial Summary

The current AWKNF market cap is 4.91M. The company's latest EPS is CAD -0.2609 and P/E is -0.54.

Year End January 30 2023 20222023
CAD ($)CAD ($)
Total Revenue 246k1.5M
Operating Income -9.78M-9.19M
Net Income -15.95M-9.14M
Year End January 30 2023 20222023
CAD ($)CAD ($)
Total Assets 6.88M4.39M
Total Liabilities 3.85M4.44M
Total Equity 3.02M-49k

Cash Flow

Year End January 30 2023 20222023
CAD ($)CAD ($)
Operating -8.59M-7.36M
Investing -1.69M-95k
Financing 11.5M6.4M
Market Cap 4.91M
Price to Earnings Ratio -0.54
Price to Sales Ratio 3.28
Price to Cash Ratio 8.92
Price to Book Ratio -100.11
Dividend Yield -

Share Statistics

Shares Outstanding 35.04M
Average Volume (1 week) 1.63k
Average Volume (1 Month) 9.44k
52 Week Change -21.57%
52 Week High 0.337
52 Week Low 0.0422
Spread (Intraday) 0.07 (41.18%)

Company Info

Company Name Awakn Life Sciences Corporation (QB)
Address 301‐217 queen street w
toronto, ontario M5V 0R2
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock